Bio Essence Corporation
BIOE
$0.23
$0.0188.49%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -84.96% | 9.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -84.96% | 9.58% | |||
| Cost of Revenue | -96.07% | -24.21% | |||
| Gross Profit | -80.73% | 31.98% | |||
| SG&A Expenses | 119.13% | -54.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 58.18% | -48.88% | |||
| Operating Income | -5,358.97% | 102.66% | |||
| Income Before Tax | -645.65% | 97.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -645.65% | 97.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -645.65% | 97.70% | |||
| EBIT | -5,358.97% | 102.66% | |||
| EBITDA | -5,100.00% | 102.80% | |||
| EPS Basic | -671.43% | 97.78% | |||
| Normalized Basic EPS | -580.00% | 79.17% | |||
| EPS Diluted | -671.43% | 97.78% | |||
| Normalized Diluted EPS | -580.00% | 79.17% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||